Global Microfluidic Devices For MPS (Microphysiological Systems) Market Research Report 2025

Publication ID:

PB502253079

Publication Date:

February 24, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Microfluidic Devices For MPS (Microphysiological Systems) was valued at US$ 373 million in the year 2024 and is projected to reach a revised size of US$ 511 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Microfluidic devices for MPS (Microphysiological Systems) are miniaturized platforms that simulate the complex physiological conditions of human tissues and organs. These devices use micro-scale fluid channels and chambers to replicate biological environments, enabling researchers to study cellular behavior, drug responses, and disease mechanisms in a controlled and reproducible way.
North American market for Microfluidic Devices For MPS (Microphysiological Systems) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microfluidic Devices For MPS (Microphysiological Systems) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Microfluidic Devices For MPS (Microphysiological Systems) include Emulate, Mimetas, uFluidix, Organovo, TissUse, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Microfluidic Devices For MPS (Microphysiological Systems), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microfluidic Devices For MPS (Microphysiological Systems).
The Microfluidic Devices For MPS (Microphysiological Systems) market size, estimations, and forecasts are provided in terms of sales volume (US$/Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microfluidic Devices For MPS (Microphysiological Systems) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microfluidic Devices For MPS (Microphysiological Systems) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Emulate
Mimetas
uFluidix
Organovo
TissUse
Segment by Type
Straight Channel
Y Channel
T-Joint
Other
Segment by Application
Drug Discovery
Disease Modeling
Toxicology
Personalized Medicine
Organs On A Chip
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microfluidic Devices For MPS (Microphysiological Systems) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microfluidic Devices For MPS (Microphysiological Systems) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Microfluidic Devices For MPS (Microphysiological Systems) Market Overview
1.1 Product Definition
1.2 Microfluidic Devices For MPS (Microphysiological Systems) by Type
1.2.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Straight Channel
1.2.3 Y Channel
1.2.4 T-Joint
1.2.5 Other
1.3 Microfluidic Devices For MPS (Microphysiological Systems) by Application
1.3.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Value by Application (2024 VS 2031)
1.3.2 Drug Discovery
1.3.3 Disease Modeling
1.3.4 Toxicology
1.3.5 Personalized Medicine
1.3.6 Organs On A Chip
1.3.7 Other
1.4 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Size Estimates and Forecasts
1.4.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue 2020-2031
1.4.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales 2020-2031
1.4.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microfluidic Devices For MPS (Microphysiological Systems) Market Competition by Manufacturers
2.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microfluidic Devices For MPS (Microphysiological Systems), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microfluidic Devices For MPS (Microphysiological Systems), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microfluidic Devices For MPS (Microphysiological Systems), Product Type & Application
2.7 Global Key Manufacturers of Microfluidic Devices For MPS (Microphysiological Systems), Date of Enter into This Industry
2.8 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Competitive Situation and Trends
2.8.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Microfluidic Devices For MPS (Microphysiological Systems) Players Market Share by Revenue
2.8.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Scenario by Region
3.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Region: 2020-2031
3.2.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Region: 2020-2025
3.2.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Region: 2026-2031
3.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Region: 2020-2031
3.3.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Region: 2020-2025
3.3.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Region: 2026-2031
3.4 North America Microfluidic Devices For MPS (Microphysiological Systems) Market Facts & Figures by Country
3.4.1 North America Microfluidic Devices For MPS (Microphysiological Systems) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microfluidic Devices For MPS (Microphysiological Systems) Sales by Country (2020-2031)
3.4.3 North America Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microfluidic Devices For MPS (Microphysiological Systems) Market Facts & Figures by Country
3.5.1 Europe Microfluidic Devices For MPS (Microphysiological Systems) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microfluidic Devices For MPS (Microphysiological Systems) Sales by Country (2020-2031)
3.5.3 Europe Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microfluidic Devices For MPS (Microphysiological Systems) Market Facts & Figures by Region
3.6.1 Asia Pacific Microfluidic Devices For MPS (Microphysiological Systems) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microfluidic Devices For MPS (Microphysiological Systems) Sales by Region (2020-2031)
3.6.3 Asia Pacific Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Microfluidic Devices For MPS (Microphysiological Systems) Market Facts & Figures by Country
3.7.1 Latin America Microfluidic Devices For MPS (Microphysiological Systems) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microfluidic Devices For MPS (Microphysiological Systems) Sales by Country (2020-2031)
3.7.3 Latin America Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Microfluidic Devices For MPS (Microphysiological Systems) Market Facts & Figures by Country
3.8.1 Middle East and Africa Microfluidic Devices For MPS (Microphysiological Systems) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microfluidic Devices For MPS (Microphysiological Systems) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Type (2020-2031)
4.1.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Type (2020-2025)
4.1.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Type (2026-2031)
4.1.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales Market Share by Type (2020-2031)
4.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Type (2020-2031)
4.2.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Type (2020-2025)
4.2.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Type (2026-2031)
4.2.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue Market Share by Type (2020-2031)
4.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Application (2020-2031)
5.1.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Application (2020-2025)
5.1.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales by Application (2026-2031)
5.1.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Sales Market Share by Application (2020-2031)
5.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Application (2020-2031)
5.2.1 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Application (2020-2025)
5.2.2 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue by Application (2026-2031)
5.2.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Revenue Market Share by Application (2020-2031)
5.3 Global Microfluidic Devices For MPS (Microphysiological Systems) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Company Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Microfluidic Devices For MPS (Microphysiological Systems) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Emulate Microfluidic Devices For MPS (Microphysiological Systems) Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 Mimetas
6.2.1 Mimetas Company Information
6.2.2 Mimetas Description and Business Overview
6.2.3 Mimetas Microfluidic Devices For MPS (Microphysiological Systems) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mimetas Microfluidic Devices For MPS (Microphysiological Systems) Product Portfolio
6.2.5 Mimetas Recent Developments/Updates
6.3 uFluidix
6.3.1 uFluidix Company Information
6.3.2 uFluidix Description and Business Overview
6.3.3 uFluidix Microfluidic Devices For MPS (Microphysiological Systems) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 uFluidix Microfluidic Devices For MPS (Microphysiological Systems) Product Portfolio
6.3.5 uFluidix Recent Developments/Updates
6.4 Organovo
6.4.1 Organovo Company Information
6.4.2 Organovo Description and Business Overview
6.4.3 Organovo Microfluidic Devices For MPS (Microphysiological Systems) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Organovo Microfluidic Devices For MPS (Microphysiological Systems) Product Portfolio
6.4.5 Organovo Recent Developments/Updates
6.5 TissUse
6.5.1 TissUse Company Information
6.5.2 TissUse Description and Business Overview
6.5.3 TissUse Microfluidic Devices For MPS (Microphysiological Systems) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 TissUse Microfluidic Devices For MPS (Microphysiological Systems) Product Portfolio
6.5.5 TissUse Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microfluidic Devices For MPS (Microphysiological Systems) Industry Chain Analysis
7.2 Microfluidic Devices For MPS (Microphysiological Systems) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microfluidic Devices For MPS (Microphysiological Systems) Production Mode & Process Analysis
7.4 Microfluidic Devices For MPS (Microphysiological Systems) Sales and Marketing
7.4.1 Microfluidic Devices For MPS (Microphysiological Systems) Sales Channels
7.4.2 Microfluidic Devices For MPS (Microphysiological Systems) Distributors
7.5 Microfluidic Devices For MPS (Microphysiological Systems) Customer Analysis
8 Microfluidic Devices For MPS (Microphysiological Systems) Market Dynamics
8.1 Microfluidic Devices For MPS (Microphysiological Systems) Industry Trends
8.2 Microfluidic Devices For MPS (Microphysiological Systems) Market Drivers
8.3 Microfluidic Devices For MPS (Microphysiological Systems) Market Challenges
8.4 Microfluidic Devices For MPS (Microphysiological Systems) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Emulate
Mimetas
uFluidix
Organovo
TissUse

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂